by Ageing and Longevity | May 7, 2023 | Uncategorized
Global investment firm EQT Life Sciences announced the close of its €260 million LSP Dementia Fund, outstripping its target fund size of €100 million. EQT is Europe’s largest healthcare buyout firm, with approximately €113.0 billion in assets under management....
Read More
by Ageing and Longevity | Jan 24, 2023 | Uncategorized
Summary: Main takeaway – the future of cellular reprogramming is bright, but there are still major hurdles to overcome before the technology can be used in a clinical setting. Cellular reprogramming is the process of reverting a cell to an earlier state. This paper...
Read More
by Ageing and Longevity | Dec 8, 2022 | Uncategorized
Summary: Main takeaway – continuing partial cellular reprogramming a bit further than most previous attempts seems to result in more substantial rejuvenation. Usually, scientists stop partial reprogramming in the initiation phase, when cells still have not lost their...
Read More
by Ageing and Longevity | Feb 7, 2022 | Uncategorized
More than two years have passed since COVID-19 became a global pandemic, and it is still very much a public health issue for everyone. While many countries have loosened control over the disease considering the reduced virulence of the more infectious SARS-CoV2...
Read More
by Ageing and Longevity | May 13, 2021 | Uncategorized
Using whole genome sequencing, an international team of scientists have potentially uncovered the secret to how semi-supercentenarians and supercentenarians live so long. The team showed that these individuals had efficient DNA repair mechanisms with reduced...
Read More
